Cargando…
An unusual case of miliary PML-IRIS in an HIV+ patient
Autores principales: | Cuendet, David, Sarro, Rossella, Merz, Laurent, Jiménez, Mayté Castro, Maeder, Philippe, Du Pasquier, Renaud, Tsouni, Pinelopi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473180/ https://www.ncbi.nlm.nih.gov/pubmed/28638853 http://dx.doi.org/10.1212/NXI.0000000000000370 |
Ejemplares similares
-
Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
por: Bsteh, Gabriel, et al.
Publicado: (2017) -
Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
por: Hodecker, Sibylle C., et al.
Publicado: (2017) -
CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments
por: Bernard-Valnet, Raphael, et al.
Publicado: (2021) -
Pembrolizumab as a treatment for PML?: Waiting for Godot
por: Du Pasquier, Renaud A.
Publicado: (2019) -
Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate
por: Baharnoori, Moogeh, et al.
Publicado: (2016)